Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Preclinical Studies Database
  • Healthcare Investors
  • Healthcare Companies

Tag Archives: Kevin Buchi

Benitec – gene silencing by ddRNAi

Posted on by

DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.

Benitec – gene silencing by ddRNAi

Benitec

Continue reading →

Posted in Biotech Companies, Biotech Companies Australia, Biotech Companies USA | Tagged AAV, adenovirus, AIDS, Benitec, Benitec - gene silencing by ddRNAi, Benitec Biopharma, BenitecBiopharma, Carl Stubbings, David Suhy, ddRNAi, DNA, DNA-directed RNA Interference, double stranded RNA, dsRNA, gene silencing, gene silencing by ddRNAi, gene silencing ddRNAi, Greg West, Hepatitis B, Hepatitis C, HIV, human cancer vaccines, Huntington's Disease, Iain Ross, John Chiplin, Kevin Buchi, lentivirus, lung cancer, Michael Graham, modified polyethylenimine, muscular dystrophy, oculopharyngeal, orphan genetic disease, Peter Francis, Peter French, Retinitis Pigmentosa, RNA, RNAi, short hairpin RNA, shRNA, siRNA, wet Age-related Macular Degeneration

Do you need to raise your next Funding round? In-Licensing / Out-Licensing of your assets? Distribution / Commercialization of your products? Want to create a spin-off with your IP?

Contact us!

Do you need a specific database in Healthcare (researchers, Biotech/Pharma companies, CRO/CDMO, etc.)?

Contact us!

Contact              Offers - Services - Licensing - Funding               Healthcare Venture Building               Biotech Jobs               Biotech & Pharma News
Proudly powered by WordPress